Autor: |
Goree JH; Anesthesiology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA jhgoree@uams.edu., Tobey-Moore LR; Psychiatric Research Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Petersen E; University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., White C; Department of Physical Medical and Rehabilitation, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Judkins D; Prestige Spine, Conway, Arkansas, USA., Brown GA; University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Virmani T; Department of Neurology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. |
Abstrakt: |
Competing Interests: Competing interests: JHG has received consultant fees from Abbott Medical, Saluda, and Stratus Medical. JHG receives research support from the Mainstay Medical and SPR Therapeutics. EP has received consultant fees from Abbott/St Jude Medical, Medtronic Neuromodulation, Nevro, Neuros Medical, Saluda, Vertos, and ReNeuron. EP receives research and education support from Nevro, Neuros Medical, ReNeuron, Saluda, and Medtronic Neuromodulation. EP has stock options in SynerFuse. LRT-M, CW, DJ, and GAB wish to declare no competing interests or financial disclosures. |